BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1181 related articles for article (PubMed ID: 11744011)

  • 21. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury.
    Altavilla D; Deodato B; Campo GM; Arlotta M; Miano M; Squadrito G; Saitta A; Cucinotta D; Ceccarelli S; Ferlito M; Tringali M; Minutoli L; Caputi AP; Squadrito F
    Cardiovasc Res; 2000 Aug; 47(3):515-28. PubMed ID: 10963724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mechanistic basis of infarct healing.
    Frangogiannis NG
    Antioxid Redox Signal; 2006; 8(11-12):1907-39. PubMed ID: 17034340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblasts in myocardial infarction: a role in inflammation and repair.
    Shinde AV; Frangogiannis NG
    J Mol Cell Cardiol; 2014 May; 70():74-82. PubMed ID: 24321195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial ischemia, reperfusion and free radical injury.
    Lucchesi BR
    Am J Cardiol; 1990 May; 65(19):14I-23I. PubMed ID: 1692444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Yue Tl TL; Chen J; Bao W; Narayanan PK; Bril A; Jiang W; Lysko PG; Gu JL; Boyce R; Zimmerman DM; Hart TK; Buckingham RE; Ohlstein EH
    Circulation; 2001 Nov; 104(21):2588-94. PubMed ID: 11714655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
    Prabhu SD; Frangogiannis NG
    Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of neutrophils in myocardial ischemia-reperfusion injury.
    Jordan JE; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1999 Sep; 43(4):860-78. PubMed ID: 10615413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A
    Alter C; Ding Z; Flögel U; Scheller J; Schrader J
    Am J Physiol Heart Circ Physiol; 2019 Jul; 317(1):H190-H200. PubMed ID: 31050560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy.
    Xia Y; Frangogiannis NG
    Inflamm Allergy Drug Targets; 2007 Jun; 6(2):101-7. PubMed ID: 17692033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of xiongshao capsule combined with ischemic postconditioning on monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in rat myocardium with ischemic reperfusion injury].
    Zhang DW; Zhang L; Liu JG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1279-83. PubMed ID: 21302491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury.
    Onai Y; Suzuki J; Kakuta T; Maejima Y; Haraguchi G; Fukasawa H; Muto S; Itai A; Isobe M
    Cardiovasc Res; 2004 Jul; 63(1):51-9. PubMed ID: 15194461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is inflammation good for the ischemic heart--perspectives beyond the ordinary.
    Entman ML; Youker KA; Frangogiannis N; Lakshminarayanan V; Nossuli T; Evans A; Kurrelmeyer K; Mann DL; Smith CW
    Z Kardiol; 2000; 89 Suppl 9():IX/82-7. PubMed ID: 11151802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of myocardial reperfusion injury.
    Park JL; Lucchesi BR
    Ann Thorac Surg; 1999 Nov; 68(5):1905-12. PubMed ID: 10585102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiopulmonary bypass-induced inflammation: is it important?
    Hill GE
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DITPA, a thyroid hormone analog, reduces infarct size and attenuates the inflammatory response following myocardial ischemia.
    Abohashem-Aly AA; Meng X; Li J; Sadaria MR; Ao L; Wennergren J; Fullerton DA; Raeburn CD
    J Surg Res; 2011 Dec; 171(2):379-85. PubMed ID: 21658725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo.
    Jin YC; Kim CW; Kim YM; Nizamutdinova IT; Ha YM; Kim HJ; Seo HG; Son KH; Jeon SJ; Kang SS; Kim YS; Kam SC; Lee JH; Chang KC
    Eur J Pharmacol; 2009 Jul; 614(1-3):91-7. PubMed ID: 19401198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MCSF expression is induced in healing myocardial infarcts and may regulate monocyte and endothelial cell phenotype.
    Frangogiannis NG; Mendoza LH; Ren G; Akrivakis S; Jackson PL; Michael LH; Smith CW; Entman ML
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H483-92. PubMed ID: 12689859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury.
    Kaminski KA; Bonda TA; Korecki J; Musial WJ
    Int J Cardiol; 2002 Nov; 86(1):41-59. PubMed ID: 12243849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.